PETCO HEALTH CL.A DL-,001

At the Goldman Sachs conference, Petco unveiled a new, growth-focused phase of its turnaround after reporting two consecutive quarters of positive same-store sales growth. The strategy emphasizes company-run services, omnichannel capabilities, differentiated products and a relaunched loyalty program, while continuing to work on debt reduction and margin improvement. Net leverage fell from 4.2x at the start of 2025 to 2.8x EBITDA, with a 2.0x target; Petco sees its veterinary network as a growth driver and is testing prototype stores ahead of a rollout decision. Management expects ongoing consumer pressure and stable prices through the end of 2026 and is prioritizing differentiation over price leadership. » More on de.investing.com

Petco reported Q2 2026 revenue of $1.5 billion and comparable-store growth of 0.6%, its second consecutive positive quarter. Adjusted EBITDA was $122 million and gross margin rose to 39.7%, prompting a sharp after-hours stock gain. Management reaffirmed the full-year outlook (revenue 0–1.5%, adjusted EBITDA $415–430 million) and emphasized progress in stores, digital, services and veterinary. Petco reported strong growth in the cat segment, weakness in dogs, plans 15–20 net store closures and continues to prioritize debt reduction. » More on de.investing.com

Chief people officer Holly May sold 200,000 Class A common shares of Petco Health and Wellness Company on July 9 at a weighted average price of $2.54 per share (transaction range $2.51–$2.60). The sale amounted to roughly $508,000; after the transaction May beneficially owns 1,327,867 shares, including 1,326,218 RSUs. The stock came under about 1.6% pressure in premarket trading after the insider sale became known. » More on de.investing.com